Excedrin Won the Debate on Twitter Before It Even Started by Curing Your #DebateHeadache

Generated a 3,100% lift in chatter

Adweek's annual #Brandweek summit will explore the ideas behind breakthrough successes, discuss solutions to pressing challenges and explore new opportunities in the Metaverse. Join leaders from Alo Yoga, Hyundai Motor America, Frito-Lay and more, Sept. 12–16 in Miami. Sign up early to save.

It all started with what seemed like another forgettable promoted trend ad on Twitter on Wednesday morning. Excedrin, the pain reliever, was trying to poke a little fun at how agonized and obsessed the American public has become with the presidential race between Donald Trump and Hillary Clinton, as the GOP and Democratic nominees were set to do some verbal jousting once more in their third and final debate later on in the day. 

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in

Your sites feature HTML here...